A-shares open · 港股交易中 Quotes 行情 · 28 Sep 13:46 CST
28 Sep 2026 · 13:46 CST Terminal Access 终端入口 →
600129.SH上海证券交易所 · 主板 Main

Taiji Group 太极集团

Traditional Chinese Medicine 中药Ⅱ
¥13.22−¥0.11 · −0.83%Live 实时 · 28 Sep 2026 · 13:46 CST · CNY
Open 开盘
¥13.36
High 最高
¥13.50
Low 最低
¥13.17
Prev Close 昨收
¥13.33
Volume 成交量
459.3万股
Turnover 成交额
¥6,092.9万
Mkt Cap 总市值
¥73亿
P/E 市盈率
104.7×
Recent Activity 近期动态All Filings 全部公告 →

6 significant filings since 31 May 2026: 1 on bankruptcy or restructuring, 2 on share pledge and 2 on pledge released, and 1 other kind. The latest, on 24 Sep 2026: 太极集团关于全资子公司破产重整的进展公告.
自 31 May 2026 起有 6 份重大公告:bankruptcy or restructuring 1 份、share pledge 2 份、pledge released 2 份,另有 1 类。最新一份(24 Sep 2026):太极集团关于全资子公司破产重整的进展公告。

Price History 价格走势

1 session 个交易日, Mon 28 Sep 2026 · Live one-minute prices · High 最高 ¥13.41 · Low 最低 ¥13.18 · −0.83% on the previous close of ¥13.33
13.2013.2513.3013.3513.40
Volume 成交量
1,763
09:3010:1210:5413:0513:47

Against Its Own History 与自身历史比较

104.7×
Median 中值 41.6× · Range 区间 21.4× to 494.4× · 13 periods 期
2.03×
Median 中值 4.19× · Range 区间 2.08× to 9.15× · 20 periods 期

Period by Period 逐期

Period 报告期Close at Period End 期末收盘TTM EPS 滚动每股收益 BPS 每股净资产
30 Jun 2026 中报¥13.57¥0.13104.4×¥6.512.08×
31 Mar 2026 一季报¥16.68¥0.2179.4×¥6.472.58×
31 Dec 2025 年报¥18.05¥0.2282.0×¥6.352.84×
30 Sep 2025 三季报¥21.88−¥0.63—¥6.423.41×
30 Jun 2025 中报¥21.31−¥0.59—¥6.523.27×
31 Mar 2025 一季报¥20.96−¥0.26—¥6.403.27×
31 Dec 2024 年报¥24.72¥0.05494.4×¥6.273.94×
30 Sep 2024 三季报¥28.06¥1.1025.5×¥7.183.91×
30 Jun 2024 中报¥28.92¥1.3521.4×¥7.094.08×
31 Mar 2024 一季报¥33.25¥1.5022.2×¥6.954.79×
31 Dec 2023 年报¥46.46¥1.4831.4×¥6.507.14×
30 Sep 2023 三季报¥46.66¥1.5430.3×¥6.856.81×
30 Jun 2023 中报¥59.49¥1.4341.6×¥6.509.15×
31 Mar 2023 一季报¥42.89¥1.0242.0×¥5.917.26×
31 Dec 2022 年报¥30.06¥0.6447.0×¥5.505.46×
30 Sep 2022 三季报¥24.14−¥0.93—¥5.344.52×
30 Jun 2022 中报¥21.97−¥0.85—¥5.114.30×
31 Mar 2022 一季报¥22.52−¥0.94—¥4.934.57×
31 Dec 2021 年报¥22.46−¥0.94—¥4.904.59×
30 Sep 2021 三季报¥14.82¥0.5427.4×¥6.262.37×

Consensus Forward EPS 机构预测每股收益

No broker forecasts for this company yet 暂无机构预测

Not Computed 未计算
  • Dividend Yield 股息率
  • Free Cash Flow 自由现金流
  • EV/EBITDA